<DOC>
	<DOCNO>NCT00013156</DOCNO>
	<brief_summary>Lung volume reduction surgery ( LVRS ) advance therapy significantly improve quality life patient COPD , date control study evaluate impact LVRS .</brief_summary>
	<brief_title>Cost-Effectiveness Lung Volume Reduction Surgery</brief_title>
	<detailed_description>Background : Lung volume reduction surgery ( LVRS ) advance therapy significantly improve quality life patient COPD , date control study evaluate impact LVRS . Objectives : Evaluate cost-effectiveness LVRS compare current therapy COPD . Methods : This case control study veteran undergo LVRS VA Puget Sound Health Care System ( VAPSHCS ) compare patient similar severity disease Boise VAMC undergo LVRS . Changes health relate quality life evaluate use three instrument : SF-36 , St. Georgeï¿½s Respiratory Questionnaire , Quality Well-Being Scale , latter calculate utility associate different health state . Costs determine use utilization data outpatient visit , medication , oxygen use , inpatient day , radiology test , laboratory test , emergency room visit collect twelve month surgery . Costs calculate accord VA community standard . Status : Complete .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<criteria>Severe COPD define FEV1 2030 % predict ; mark hyperinflation residual volume &gt; 165 % predict ; 6min walk great 600 ft ; abstinence cigarette smoke 3mths ; absence comorbid illness would significantly increase surgical risk , severe coronary artery disease</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>